Vaccine which should not be given to an elderly man is
**Question:** Vaccine which should not be given to an elderly man is
A. Influenza vaccine
B. Pneumococcal vaccine
C. Hepatitis B vaccine
D. Measles, mumps, and rubella (MMR) vaccine
**Correct Answer:** D. Measles, mumps, and rubella (MMR) vaccine
**Core Concept:** Immunosenescence is the age-related decline in the immune system that occurs in elderly individuals, making them more susceptible to infections and less effective in responding to vaccines.
**Why the Correct Answer is Right:** Measles, mumps, and rubella (MMR) vaccines are live attenuated vaccines, meaning they contain live but weakened viruses that stimulate the immune system to produce an immune response. In elderly individuals, the risk of severe complications from the live attenuated viruses in the vaccine outweighs the benefits, especially when compared to the risk of severe complications from these diseases.
**Why Each Wrong Option is Incorrect:**
A. Influenza vaccine: Although elderly individuals are at higher risk for severe disease due to influenza, the inactivated (killed) influenza vaccine is generally safe for this population. Live attenuated vaccines are generally avoided in the elderly.
B. Pneumococcal vaccine: Live vaccines are not used for pneumococcal vaccines. The pneumococcal vaccine is a polysaccharide vaccine, which does not pose the same risks as live attenuated vaccines.
C. Hepatitis B vaccine: Hepatitis B vaccine is generally safe for the elderly, although the immune response may be reduced. The risks associated with the disease itself (hepatitis B) often outweigh the risks of vaccination in this population.
**Why Each Wrong Option is Incorrect:**
Option D (MMR vaccine) is the correct answer as it is a live attenuated vaccine, specifically containing the live, attenuated measles, mumps, and rubella viruses. This option poses a higher risk to the elderly population due to potential complications from the live viruses. In comparison, options A, B, C, and D have different types of vaccines with varying levels of safety concerns in the elderly population.
**Clinical Pearl:** Immunosenescence is a well-known phenomenon which occurs in elderly individuals, where their immune system undergoes changes leading to a decline in immune function. These changes include reduced immune response, increased susceptibility to infections, and an increased risk of severe complications from vaccines, as in the case of MMR vaccine. It is essential for medical professionals to consider these changes when counseling elderly patients about vaccinations and selecting appropriate vaccines for their patients.